Clinical Trials Sponsored by Nuance Hearing

Total 4848 results

Nuance Hearing

Unknown

"Nuance Hearing" for Attention Deficit Hyperactivity Disorder (ADHD)

Attention Deficit Hyperactivity Disorder
GN Hearing A/S

Not yet recruiting

Asymmetrical Directionality With Bimodal Systems.

Hearing Loss
Ferring Pharmaceuticals
Ferring SAU

Completed

Assessment of the Effectiveness of Menopur in Intrauterine Insemination

Infertility

Spain
Ferring Pharmaceuticals
Ferring SAU

Completed

Adipocyte Function and Somtropin Deficiency (FAYDS)

Growth Hormone Deficiency

Spain
Ferring Pharmaceuticals
Ferring SAU

Completed

Assessment of the Effectiveness and Tolerability of Ovarian Hyperstimulation (DESCARTES)

STERILITY

Spain
Ferring Pharmaceuticals
Ferring SAU

Completed

Comparative Assessment of the Clinical Utility of Ovarian Stimulation With Menotropin Versus Menotropin Plus GnRH Antagonist (PROMENIA)

Sterility

Spain
Ferring Pharmaceuticals
Ferring SAU

Completed

Assessment of the Therapeutic Utility of hMG-HP

Sterility

Spain
The Hearing Cooperative Research Centre
Cochlear; Attune Hearing; Sydney Cochlear Implant Clinic

Completed

Outcome Prediction in Cochlear Implant Recipients

Hearing Loss

Australia
National Healing Corporation

Withdrawn

Clinical Effectiveness of Topical Autologous Platelet Gel for the Treatment of Venous Ulcers

Venous Ulcer

United States
Sonova AG
Hearts for Hearing

Completed

Optimizing Soft Speech Recognition in Children With Hearing Loss (SoftSpeech)

Hearing Loss, Sensorineural | Hearing Loss, Bilateral

United States
Sonova AG
Hearts for Hearing

Completed

Benefit of Assistive Listening Device for Lateralization

Hearing Loss, Sensorineural

United States
Sonova AG
Hearts for Hearing

Completed

Benefits of Assistive Listening Device for Speech Intelligibility

Hearing Loss

United States
Ferring Pharmaceuticals
Ferring SAU

Completed

Assessment of the Therapeutic Utility of r-FSH in Association With hMG-HP

Sterility

Spain
GN Hearing A/S
Northwestern University; Vanderbilt University; Sertoma Speech and Hearing Center

Completed

Wear-Time Trial for Self-Fitting Hearing Aid

Hearing Loss, Sensorineural

United States
Ferring Pharmaceuticals
Ferring Arzneimittel GmbH

Completed

Effectiveness and Safety of Firmagon® (FAST)

Androgen Ablative Therapy of Advanced Hormone-dependent Prostate Carcinoma

Germany
Ferring Pharmaceuticals
Ferring Arzneimittel GmbH

Completed

Progesterone Serum Levels in Subfertile Female Patients Undergoing in Vitro Fertilisation (IVF) (PREDICT)

Infertility

Germany
Ferring Pharmaceuticals
Ferring Arzneimittel GmbH

Completed

Compliance and Efficacy in the Use of PICOPREP® (CLEAR)

Bowel Cleanliness

Germany
Ferring Pharmaceuticals
Ferring Arzneimittel GmbH

Completed

Quality of Life With TESTIM® (LIFE)

Hypogonadism

Germany
Ferring Pharmaceuticals
Ferring Arzneimittel GmbH

Completed

User Surveillance in Ulcerative Colitis (CARE)

Ulcerative Colitis

Germany
PBM Healing International Limited

Recruiting

Impact of Photobiomodulation on Pain During Orthodontic Treatment.

Malocclusion | Orthodontic Treatment

Canada
Pranic Healing Research Institute

Completed

Changes in Microbiota in Healthy Subjects Before and After Meditation Practices in a Controlled Environment

Healthy

United States
PBM Healing International Limited

Completed

Impact of Photobiomodulation on Pain Associated With Orthodontic Treatment

Pain | Orthodontic

Japan
Ferring Pharmaceuticals
Ferring Arzneimittel GmbH

Completed

Online Surveillance of Treatment of Children With Growth Hormone Deficiency With ZOMACTON

Growth Hormone Deficiency

Germany
Ferring Pharmaceuticals
Ferring Arzneimittel GmbH

Completed

Mesalazine (PENTASA®) in Ulcerative Colitis (MUKOSA)

Ulcerative Colitis

Germany
Ferring Pharmaceuticals
Ferring Arzneimittel GmbH

Completed

MINRIN® Orally Disintegrating Tablet (Fast Dissolving Desmopressin) and Tablets in Treatment of Primary Nocturnal Enuresis (MELT)

Nocturnal Enuresis

Germany
Sonova AG
Sound Relief Hearing Center

Completed

Evaluation of New Fitting Characteristics for Extended Wear Hearing Aid Technology

Hearing Loss

United States
Ferring Pharmaceuticals

Recruiting

A Study Investigating the Safety, Tolerability, Immunogenicity and Pharmacokinetics of Olamkicept in Healthy Persons

Inflammatory Gastrointestinal Diseases

Germany
Ferring Pharmaceuticals

Recruiting

A Phase 1b Proof-of-concept Trial Exploring the Effects of FE 999322 and FE 999324 in Adults With Mild to Moderate Ulcerative Colitis

Ulcerative Colitis

United States
CSL Behring

Recruiting

Efficacy and Safety of CSL222 (Etranacogene Dezaparvovec) Gene Therapy in Adults With Hemophilia B With Pretreatment Adeno-associated Virus Serotype 5 (AAV5) Neutralizing Antibodies (Nabs)

Hemophilia B

United States, Canada, Israel
Ferring Pharmaceuticals

Recruiting

A Multi-center, Single-arm Trial Exploring the Safety and Clinical Effectiveness of RBX2660 Administered by Colonoscopy to Adults With Recurrent Clostridioides Difficile Infection (CDI-SCOPE)

Clostridium Difficile Infection Recurrence

United States
Ferring Pharmaceuticals

Recruiting

A Trial to Compare the Ovarian Response of REKOVELLE and GONAL-F in Conventional Dosing in Women Undergoing Controlled Ovarian Stimulation (ADAPT-1)

Infertility

Italy, Spain, France, United Kingdom, Austria
CSL Behring

Recruiting

Observatory of Patients With Haemophilia B Treated by IdElvion® (OrPHEe)

Haemophilia B

France
Ferring Pharmaceuticals

Recruiting

NOCDURNA PASS Study Using Registries in Denmark, Germany and Sweden

Adverse Drug Event

Germany
CSL Behring

Recruiting

The Safety and Efficacy of Alpha-1 Antitrypsin (AAT) for the Prevention of Graft-Versus-host Disease (GVHD) in Patients Receiving Hematopoietic Cell Transplant (MODULAATE)

Acute-graft-versus-host Disease

United States, Korea, Republic of, Spain, Australia, Germany, Italy, Turkey, Japan
CSL Behring

Recruiting

Two Dose Levels of Privigen in Pediatric CIDP

Pediatric Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

United States
Herning Hospital

Not yet recruiting

Laser Treatment of Genito-urinary Syndrome in Women

Breast Cancer | Menopause | Vaginal Atrophy | Endometrial Cancer | Bladder, Overactive | Laser-Induced Scar

Denmark
CSL Behring

Active, not recruiting

Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis

End Stage Kidney Disease | Atherosclerotic Cardiovascular Disease

United States, Australia, Belgium, Canada, Germany
CSL Behring

Completed

Study to Investigate CSL112 in Subjects With Acute Coronary Syndrome (AEGIS-II)

Acute Coronary Syndrome

United States, Argentina, Australia, Austria, Belgium, Brazil, Bulgaria, Canada, Chile, Colombia, Croatia, Czechia, Denmark, Estonia, Finland, France, Georgia, Germany, Greece, Hong Kong, Hungary, Israel, Italy, Japan, Korea, Republic of, Latvi... and more
CSL Behring

Completed

Registry of Patients With Von WilLEbrand Disease Treated With Voncento® (OPALE)

Von Willebrand Disease

France
CSL Behring

Active, not recruiting

Study of AAV5-hFIX in Severe or Moderately Severe Haemophilia B

Hemophilia B

Netherlands, Germany
CSL Behring

Enrolling by invitation

Long-term Follow-up Study of Male Adults With Hemophilia B Previously Treated With Etranacogene Dezaparvovec (CSL222)

Hemophilia B

United States
CSL Behring

Completed

A Clinical Study to Test the Safety, Exposure, and Pharmacodynamic Markers of CSL311 in Patients With Mild-to-moderate Asthma and in Healthy Volunteers

Asthma

United Kingdom, Germany
Ferring Pharmaceuticals

Terminated

Impact of Blastocyst Morphological Development and Blastocoele Re-expansion on Pregnancy Outcome After Using REKOVELLE®

Controlled Ovarian Stimulation

Denmark
Ferring Pharmaceuticals

Completed

Dose Finding Trial With a New Treatment (Degarelix) for Prostate Cancer

Prostate Cancer

Netherlands, Belgium, Germany, Russian Federation, South Africa, Hungary, Romania, Poland
CSL Behring

Completed

Effects of CSL324 in the Lung After Segmental Challenge

Healthy Volunteers

Germany
Ferring Pharmaceuticals

Completed

Evaluation of Overall Compliance and Duration of Zomacton® Treatment With the Zomajet® Needle-free Device (ZOMAJET)

Turner's Syndrome | Human Growth Hormone Deficiency

France
Ferring Pharmaceuticals

Completed

Semapimod for Treatment of Moderate to Severe Crohn's Disease 1 or 3 Days' Treatment Versus Placebo (CD04)

Crohn's Disease

United States, Netherlands, Israel, Belgium, Germany
Ferring Pharmaceuticals

Completed

Comparison of MENOPUR Liquid and Powder in Women Undergoing Assisted Reproductive Technology (ART) (CLARA)

Infertility

United States
Ferring Pharmaceuticals

Completed

Efficacy and Safety of FE 999049 in Controlled Ovarian Stimulation in Japanese Women

Infertility

Japan
CSL Behring

Completed

CSL312 (Garadacimab) in the Prevention of Hereditary Angioedema Attacks

Hereditary Angioedema

United States, Germany, Japan, Hungary, Canada, Netherlands, Israel

Clinical Trials Sponsored by Nuance Hearing

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kyrgyzstan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations